SCHEMBL30108006

SCHEMBL30108006

CC(C)(C)N1CCC(COc2ccc3c(c2)nnn3-c2cc(-c3ccco3)nc(N)n2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
SMARCA2 P51531 3/20 0.32
PBRM1 Q86U86 3/20 0.32
SMARCA4 P51532 2/20 0.32
NR1I2 O75469 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNB3 Q05901 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108077 0.88 SLC6A2 (0.40) CCNA2CDK2CCNA1KDM4EALDH1A1
SCHEMBL30107951 0.80 PTGS1 (0.46) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108046 0.79 KDM4E (0.39) CCNA2CDK2CCNA1KDM4EALDH1A1
SCHEMBL30107980 0.79 ROCK1 (0.45) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108068 0.78 AXL (0.35) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108028 0.77 KDM4E (0.43) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108021 0.75 KDM4E (0.36) CCNA2CDK2CCNA1KDM4EALDH1A1
SCHEMBL30107960 0.75 SLC6A2 (0.40) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30107959 0.73 KDM4E (0.44) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108012 0.73 TSHR (0.58) KDM4EALDH1A1GAAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed